Apiam Animal Health logo

AHX - Apiam Animal Health Share Price

A$0.62 -0.0  -3.1%

Last Trade - 2:21am

Sector
Healthcare
Size
Small Cap
Market Cap £78.1m
Enterprise Value £106.2m
Revenue £67.1m
Position in Universe 717th / 1844
Bullish
Bearish
Unlock AHX Revenue
Momentum
Relative Strength (%)
1m +2.74%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -15.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 54.1 98.0 106.6 111.7 118.3 127.3 133.7
+137.6 -27.8 -15.1 +22.0 +46.7 +33.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, Apiam AnimalHealth Ltd revenues increased 6% to A$118.3M. Net incomeincreased 32% to A$4.2M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Net income benefited fromProperty expenses decrease of 57% to A$1.5M (expense).Dividend per share remained flat at A$0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AHX Revenue Unlock AHX Revenue

Net Income

AHX Net Income Unlock AHX Revenue

Normalised EPS

AHX Normalised EPS Unlock AHX Revenue

PE Ratio Range

AHX PE Ratio Range Unlock AHX Revenue

Dividend Yield Range

AHX Dividend Yield Range Unlock AHX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AHX EPS Forecasts Unlock AHX Revenue
Profile Summary

Apiam Animal Health Limited is a provider of veterinary products and services to production and companion animals. The Company services production animals throughout their life cycle, including the provision of genetics, veterinary services, wholesale and retail of related products, and technical services related to food-chain security. It provides systems to assist in herd health programs; production advice; consulting services and products to assist in the prevention of animal diseases; technologies to manage compliance with legislative requirements on pharmaceutical use; advice and services in respect of animal welfare compliance; retail animal health product sales; on-farm delivery of products via its own logistics capability; third party auditing services of industry quality assurance programs; technology development for animal health management; ancillary services, such as sales and delivery of genetics-associated products, and on-farm and online training programs for clients.

Directors
Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated March 25, 2015
Public Since December 15, 2015
No. of Shareholders: 1,203
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 215,072,709
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AHX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AHX
Upcoming Events for AHX
Frequently Asked Questions for Apiam Animal Health
What is the Apiam Animal Health share price?

As of 2:21am, shares in Apiam Animal Health are trading at A$0.62, giving the company a market capitalisation of £78.1m. This share price information is delayed by 15 minutes.

How has the Apiam Animal Health share price performed this year?

Shares in Apiam Animal Health are currently trading at A$0.62 and the price has moved by 39.13% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Apiam Animal Health price has moved by 41.91% over the past year.

What are the analyst and broker recommendations for Apiam Animal Health?

Of the analysts with advisory recommendations for Apiam Animal Health, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Apiam Animal Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Apiam Animal Health next release its financial results?

Apiam Animal Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Apiam Animal Health dividend yield?

The Apiam Animal Health dividend yield is 3.13% based on the trailing twelve month period.

Does Apiam Animal Health pay a dividend?

Last year, Apiam Animal Health paid a total dividend of 0.02, and it currently has a trailing dividend yield of 3.13%. Looking ahead, Apiam Animal Health has not announced an ex-dividend date yet.

When does Apiam Animal Health next pay dividends?

Apiam Animal Health has yet to annouce their ex-dividend date. The historic dividend yield on Apiam Animal Health shares is currently 3.13%.

How do I buy Apiam Animal Health shares?

To buy shares in Apiam Animal Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Apiam Animal Health?

Shares in Apiam Animal Health are currently trading at A$0.62, giving the company a market capitalisation of £78.1m.

Where are Apiam Animal Health shares listed? Where are Apiam Animal Health shares listed?

Here are the trading details for Apiam Animal Health:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: AHX
What kind of share is Apiam Animal Health?

Based on an overall assessment of its quality, value and momentum, Apiam Animal Health is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Apiam Animal Health share price forecast 2021?

Shares in Apiam Animal Health are currently priced at A$0.62. At that level they are trading at 23.44% discount to the analyst consensus target price of 0.00.

Analysts covering Apiam Animal Health currently have a consensus Earnings Per Share (EPS) forecast of 0.06 for the next financial year.

How can I tell whether the Apiam Animal Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Apiam Animal Health. Over the past six months, the relative strength of its shares against the market has been 13.38%. At the current price of A$0.62, shares in Apiam Animal Health are trading at 17.05% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Apiam Animal Health PE Ratio?

The Apiam Animal Health PE ratio based on its reported earnings over the past 12 months is 15.65. The shares are currently trading at A$0.62.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Apiam Animal Health?

We were unable to find the directors for Apiam Animal Health.

Who are the major shareholders of Apiam Animal Health?

Here are the top five shareholders of Apiam Animal Health based on the size of their shareholding:

Richards (Christopher Irwin) Individual Investor
Percentage owned: 25.34% (30.6m shares)
Regal Funds Management Pty. Ltd. Hedge Fund
Percentage owned: 12.09% (14.6m shares)
Scolexia Commodity Pty Corporation
Percentage owned: 1.92% (2.32m shares)
Cobash Pty. Ltd. Corporation
Percentage owned: 1.55% (1.87m shares)
Hamilton Animal Health Pty. Ltd Corporation
Percentage owned: 1.23% (1.49m shares)
Similar to AHX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.